Pharmaceutical

Elsie and GSK link to accelerate oligonucleotide discovery platform

Elsie has signed a research collaboration agreement with GSK to accelerate the development of its oligonucleotide discovery platform.

Jul 11, 2023 - 20:00
Elsie and GSK link to accelerate oligonucleotide discovery platform
Elsie has signed a research collaboration agreement with GSK to accelerate the development of its oligonucleotide discovery platform.
Read the original article

Tags:

Previous Article

BeiGene to acquire DualityBio’s ADC therapy for solid tumours

Next Article

MHRA approves GSK’s RSV vaccine for older adults in the UK

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Second recipient of genetically modified pig heart dies, six weeks after surgery

Second recipient of genetically modified pig heart dies...

Nov 1, 2023

Alexion and Verge enter AI-powered drug discovery deal

Alexion and Verge enter AI-powered drug discovery deal

Sep 11, 2023

FDA approves US WorldMeds’s iwilfin for neuroblastoma

FDA approves US WorldMeds’s iwilfin for neuroblastoma

Dec 16, 2023